116 related articles for article (PubMed ID: 31512793)
1. MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer.
Hejazi M; Baghbani E; Amini M; Rezaei T; Aghanejad A; Mosafer J; Mokhtarzadeh A; Baradaran B
J Cell Biochem; 2020 Feb; 121(2):1388-1399. PubMed ID: 31512793
[TBL] [Abstract][Full Text] [Related]
2. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
3. Potential using of microRNA-34A in combination with paclitaxel in colorectal cancer cells.
Soltani-Sedeh H; Irani S; Mirfakhraie R; Soleimani M
J Cancer Res Ther; 2019; 15(1):32-37. PubMed ID: 30880751
[TBL] [Abstract][Full Text] [Related]
4. microRNA-193a-5p inhibits migration of human HT-29 colon cancer cells via suppression of metastasis pathway.
Shirafkan N; Shomali N; Kazemi T; Shanehbandi D; Ghasabi M; Baghbani E; Ganji M; Khaze V; Mansoori B; Baradaran B
J Cell Biochem; 2019 May; 120(5):8775-8783. PubMed ID: 30506718
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X
Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
10. LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer.
Wang L; Zhang X; Sheng L; Qiu C; Luo R
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126852
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK
Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111
[TBL] [Abstract][Full Text] [Related]
13. microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
Takahashi H; Takahashi M; Ohnuma S; Unno M; Yoshino Y; Ouchi K; Takahashi S; Yamada Y; Shimodaira H; Ishioka C
BMC Cancer; 2017 Nov; 17(1):723. PubMed ID: 29115941
[TBL] [Abstract][Full Text] [Related]
14. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
Li Z; Yao H; Wang S; Li G; Gu X
J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
[TBL] [Abstract][Full Text] [Related]
16. Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling.
Wang J; Min H; Hu B; Xue X; Liu Y
J Cell Biochem; 2020 Feb; 121(2):1250-1259. PubMed ID: 31489998
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
Mei M; Ren Y; Zhou X; Yuan XB; Han L; Wang GX; Jia Z; Pu PY; Kang CS; Yao Z
Technol Cancer Res Treat; 2010 Feb; 9(1):77-86. PubMed ID: 20082533
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
19. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53.
Noorolyai S; Baghbani E; Aghebati Maleki L; Baghbanzadeh Kojabad A; Shanehbansdi D; Khaze Shahgoli V; Mokhtarzadeh A; Baradaran B
Adv Pharm Bull; 2020 Jan; 10(1):130-134. PubMed ID: 32002372
[No Abstract] [Full Text] [Related]
20. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
